• $2.3M
    Market Cap
  • -42.39%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
2,415
0.00%
2,415
0.00%
2,415
-97.35%
90,985
-59.77%
Gross Profit
-2,415
0.00%
-2,415
0.00%
-2,415
-97.35%
-90,985
-59.77%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-99,625
-11.40%
-112,444
-74.95%
-448,873
+2.98%
-435,872
-17.34%
Depreciation and Amortization Expense
52,870
+9.56%
48,258
-17.44%
58,450
+1,848.33%
3,000
0.00%
Total Operating Expenses
364,188
-12.35%
415,479
-78.22%
1.9M
-18.12%
2.3M
-69.53%
Operating Profit
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
-2.3M
-69.53%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
-2.3M
-69.53%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
-2.3M
-69.53%
Net Income from Continuing Operations Applicable to Common
-364,188
-12.35%
-415,479
-78.22%
-1.9M
-18.12%
-2.3M
-69.53%
Basic EPS and Net Income
0.00
+100.00%
-0.01
N/A
N/A
N/A
0.00
+100.00%
Diluted EPS and Net Income
0.00
+100.00%
-0.01
N/A
N/A
N/A
0.00
+100.00%
Basic Weighted Average Shares
358.6M
+7.64%
333.1M
+8.36%
307.4M
+5.32%
291.9M
+4.76%
Diluted Weighted Average Shares
358.6M
+7.64%
333.1M
N/A
N/A
N/A
291.9M
+4.76%
Balance Sheet
Cash and Cash Equivalents
20,408
0.00%
20,408
-20.13%
25,550
-55.62%
57,568
-70.24%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
20,408
0.00%
20,408
-20.13%
25,550
-55.62%
57,568
-70.24%
Total Current Assets
1,050
-95.11%
21,458
-19.33%
26,600
-68.17%
83,563
-57.04%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
466,137
-3.00%
480,557
+3.82%
462,870
+3.73%
446,234
-4.89%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
0
N/A
0
N/A
Total Current Liabilities
124,047
+177.53%
44,696
+7.62%
41,530
-55.47%
93,268
+419.34%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
124,047
+177.53%
44,696
+7.62%
41,530
-55.47%
93,268
+107.45%
Retained Earnings
-48.2M
+0.76%
-47.9M
+0.88%
-47.4M
+4.19%
-45.5M
+5.44%
Total Stockholders Equity
342,090
-21.51%
435,861
+3.45%
421,340
+19.37%
352,966
-16.80%
Total Shares Outstanding
371.9M
+7.41%
346.2M
+7.23%
322.9M
+8.57%
297.4M
+4.00%
Cash Flow
Cash from Operating Activities
-223,050
-40.68%
-375,989
-53.27%
-804,669
-9.58%
-889,891
+0.97%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-58,055
-1.86%
-59,153
-55.20%
-132,049
+45.13%
-90,985
+29.65%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
256,000
-40.47%
430,000
-52.47%
904,700
+7.07%
845,000
+10.09%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-76.94%
-12.65%
-88.08%
-79.01%
-419.60%
-17.55%
-508.91%
-64.88%
Return on Equity
-93.63%
-3.42%
-96.94%
-80.32%
-492.65%
-17.81%
-599.42%
-61.40%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.009
-98.23%
0.48
-25.04%
0.64
-28.51%
0.90
-91.73%
Cash Ratio
0.16
-63.97%
0.46
-25.78%
0.62
-0.32%
0.62
-94.27%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow